- Featured Product
- KD/KO Validated
BRD7 Polyklonaler Antikörper
BRD7 Polyklonal Antikörper für WB, IHC, Indirect ELISA
Wirt / Isotyp
Kaninchen / IgG
Getestete Reaktivität
human, Maus, Ratte
Anwendung
WB, IHC, Indirect ELISA
Konjugation
Unkonjugiert
Kat-Nr. : 51009-2-PBS
Synonyme
Geprüfte Anwendungen
Produktinformation
51009-2-PBS bindet in WB, IHC, Indirect ELISA BRD7 und zeigt Reaktivität mit human, Maus, Ratten
| Getestete Reaktivität | human, Maus, Ratte |
| Wirt / Isotyp | Kaninchen / IgG |
| Klonalität | Polyklonal |
| Typ | Antikörper |
| Immunogen | BRD7 fusion protein Ag3911 |
| Vollständiger Name | bromodomain containing 7 |
| Berechnetes Molekulargewicht | 651 aa, 74 kDa |
| Beobachtetes Molekulargewicht | 70-74 kDa |
| GenBank-Zugangsnummer | BC050728 |
| Gene symbol | BRD7 |
| Gene ID (NCBI) | 29117 |
| Konjugation | Unkonjugiert |
| Form | Liquid |
| Reinigungsmethode | Antigen-Affinitätsreinigung |
| Lagerungspuffer | PBS only |
| Lagerungsbedingungen | Store at -80°C. 20ul Größen enthalten 0,1% BSA. |
Hintergrundinformationen
BRD7 (bromodomain containing 7), is a subunit of poly-bromo-associated BRG1-associated factor (PBAF)-specific Swi/Snf chromatin remodeling complexes.BRD7 is proposed as a tumor suppressor protein, since its identification as an important component of both functional p53 and BRCA1 (breast cancer 1, early onset) pathways. BRD7 could down-regulate the GSK3beta phosphotransferase activity as dephosphorylation of GSK3B at 'Tyr-216', thus activate the Wnt signaling pathway in a DVL1-dependent manner.





















